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Integration of artificial intelligence (AI) techniques in wireless infrastructure, real-time
collection, and processing of end-user devices is now in high demand. It is now
superlative to use AI to detect and predict pandemics of a colossal nature. The
Coronavirus disease 2019 (COVID-19) pandemic, which originated in Wuhan China,
has had disastrous effects on the global community and has overburdened advanced
healthcare systems throughout the world. Globally; over 4,063,525 confirmed cases
and 282,244 deaths have been recorded as of 11th May 2020, according to the
European Centre for Disease Prevention and Control agency. However, the current rapid
and exponential rise in the number of patients has necessitated efficient and quick
prediction of the possible outcome of an infected patient for appropriate treatment using
AI techniques. This paper proposes a fine-tuned Random Forest model boosted by the
AdaBoost algorithm. Themodel uses the COVID-19 patient’s geographical, travel, health,
and demographic data to predict the severity of the case and the possible outcome,
recovery, or death. The model has an accuracy of 94% and a F1 Score of 0.86 on the
dataset used. The data analysis reveals a positive correlation between patients’ gender
and deaths, and also indicates that the majority of patients are aged between 20 and
70 years.
Keywords: COVID-19, healthcare analytics, patient data, infection, boosting, random forest classification
INTRODUCTION
The healthcare industry is a vast industry that requires real time collection and processing of
medical data. Moreover, at the core of this industry lies the problem of data handling which
requires real time prediction and dissemination of information to practitioners for quick medical
attention. Major actors of this industry, such as physicians, vendors, hospitals, and health-based
companies have attempted to collect, manage, and revive data with the aim of using it to
enhance medical practices and for technological innovation. However, dealing with healthcare
data has, of late, become a complex task due to the massive volume of the data, security issues,
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wireless network application incompetence, and the velocity at
which it is increasing. Thus, to increase the efficiency, accuracy,
and workflow healthcare industries need data analytics tools to
manage such complex data.
Coronavirus disease 2019 (COVID-19) is a virus of the
Corona virus family and the source of a respiratory illness
outbreak throughout the world that originated inWuhan, China.
Studies (1–3) show that Covid-19 has clinical characteristics
akin to the SARS-CoV. The dominant symptoms include fever
and cough, while gastrointestinal symptoms are uncommon.
In COVID-19 infected patients the absence of fever is more
frequent than in patients infected by similar viruses, i.e., MERS
Corona Virus (2%) and SARS Corona Virus (1%) (4); therefore,
there is a possibility of non-febrile patients being missed by
a surveillance mechanism with a primary focus on detecting
fever (5). The initial patients infected by COVID-19, reportedly
indicated an association with a large seafood and animal market
in Wuhan that demonstrated an animal-to-person spread. Per
contra, a burgeoning number of patients have not displayed
any association with the animal markets, revealing the fact of
human-to-human transmission of COVID-19. This pandemic
has been declared a global health emergency and is spreading
at an alarming rate (6). The origin of the virus in Wuhan,
China has caused 175,694 deaths globally and has 2,544,792 active
patients globally (7). With the stress on medical facilities, it is
essential for governments and healthcare facilities to identify
and treat cases that are most likely to survive, by so doing,
judiciously utilizing the limited stock of medical resources
and medications.
Artificial Intelligence (AI) has emerged as the breakthrough
technology of the twenty-first century and has found multiple
applications in fields from weather prediction, astronomical
exploration, to autonomous systems (8). We note a few related
works where AI has been applied for detection, prevention, and
prediction to combat the COVID-19 pandemic. In Wang and
Wong (9) researchers have implemented a Convolutional Neural
Network based model to detect COVID-19 patients using CXR
images. They used a pre-trained ImageNet and trained the model
on an open source dataset of Chest X-Ray images (CXR). While
Pal et al. (10) implemented a LSTMmodel to predict the country-
specific risk of COVID-19, that relies on trends and weather
data of a particular country to predict the probable spread of
COVID-19 in that country. In Liu et al. (11) the AI practitioners
applied ML to process internet activity, news reports, health
organization reports, and media activity to predict the spread of
the outbreak on the providence level in China (12). In Bayes and
Valdivieso (13) the authors made use of the Bayesian approach
to predict the number of deaths in Peru for 70 days in the future,
using the empirical data from China. The authors in Beck et al.
(14) applied Artificial intelligence to identify the commercially
available drugs that could be used to treat COVID-19 patients.
They used Bidirectional Encoder Representations from the
Transformers (BERT) framework at the core of their model.
In Tang et al. (15) the researchers implemented the random
forest algorithm for severity analysis of COVID-19 patients
using the Computed Tomography (CT) Scans. In Khalifa et al.
(16) the authors proposed a Generative Adversarial Network
based fine-tuned model for detecting pneumonia from Chest
X-Ray scans, which is one of the symptoms of COVID-
19 infection. In Sujatha et al. (17), authors proposed a
method which could be helpful in predicting the stretch
of COVID-2019, by performing linear regression, and the
Multilayer perceptron and Vector autoregression model
which could provide an expectation on the COVID-19
Kaggle information, to anticipate the epidemiological
pattern of the disease and rate of COVID-2019 cases
in India.
Kutia et al. (18) tried to break down client perspectives
to eHealth applications in China and the eHealth framework
in the Ukraine, which afterwards provided bits of knowledge
and proposals for the improvement of an eHealth application
(eZdorovya) for mainly health information benefits. Sultan et al.
(19) presented a hybrid method that generates and facilitates
Alzheimer patients to recall their memories. This egocentric
video summary uses important people, objects, and medicines
as tools in the realization of their method. Furthermore, an
emerging tactile Internet-based nanonetwork that promises a
new range of e-health applications has been proposed by Feng
et al. (20). The authors use an information based transmit
network that goes to an operator via the terahertz band. Finally,
the authors in Jain and Chatterjee (21) presented an assortment
of strategies intended to speak to, improve, and enable multi-
disciplinary and multi-institutional ML to explore in healthcare
informatics (22). Khamparia et al. (23) introduced a unique
way of an internet of health things (IoHT)-driven deep learning
structure for identification and arrangement of cervical cancer in
Pap smear pictures, utilizing ideas of transfer learning. Waheed
et al. (24) suggested a technique to produce manufactured chest
X-ray (CXR) pictures by building up an Auxiliary Classifier
Generative Adversarial Network (ACGAN) utilized model called
CovidGAN. Sakarkar et al. (25) suggested a profound learning-
based mechanized discovery and characterization model for
fundus DR pictures.
This paper aims to fill the void of the traditional
healthcare system, using machine learning (ML) algorithms
to simultaneously process healthcare and travel data along with
other parameters of COVID-19 positive patients, in Wuhan,
to predict the most likely outcome of a patient, based on
their symptoms, travel history, and the delay in reporting the
case by identifying patterns from previous patient data. Our
contribution includes:
• Processing of healthcare and travel data using
machine learning algorithms in place of the
traditional healthcare system to identify COVID
infected person.
• This work compared multiple algorithms that are available
for processing patient data and identified the Boosted
Random Forest as the best method for processing data.
Further, it executed a grid search to fine-tune the hyper
parameters of the Boosted Random Forest algorithm to
improve performance.
• Our work obliterates the need to re-compare existing
algorithms for processing COVID-19 patient data.
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TABLE 1 | Dataset description.
Column Description Values (for
categorical
variables)
Type
id Patient Id NA Numeric
location The location where the
patient belongs to
Multiple cities
located
throughout the
world
String,
Categorical
country Patient’s native country Multiple
countries
String,
Categorical
gender Patient’s gender Male, Female String,
Categorical
age Patient’s age NA Numeric
sym_on The date patient started
noticing the symptoms
NA Date
hosp_vis Date when the patient
visited the hospital
NA Date
vis_wuhan Whether the patient
visited Wuhan, China
Yes (1), No (0) Numeric,
Categorical
from_wuhan Whether the patient
belonged to Wuhan,
China
Yes (1), No (0) Numeric,
Categorical
death Whether the patient
passed away due to
COVID-19
Yes (1), No (0) Numeric,
Categorical
Recov Whether the patient
recovered
Yes (1), No (0) Numeric,
Categorical
symptom1.
symptom2,
symptom3,
symptom4,
symptom5,
symptom6
Symptoms noticed by
the patients
Multiple
symptoms
noticed by the
patients
String,
Categorical
• This work will enable researchers to further work on
developing a solution that combines the processing of patient
demographics, travel, and subjective health data with image
data (scans) for better prediction of COVID-19 patient
health outcomes.
The rest of the article is organized as follows: section Materials
and Methods discusses the materials and methodology used in
detail, along with the dataset description, data pre-processing,
and the data analysis of the classification algorithms used. Section
Results discusses the result of the experiment followed by further
discussion in section Discussion. Section Conclusion and Future
Work discusses the results and provides a conclusion and the
future direction of the current work.
MATERIALS AND METHODS
The dependencies for the project include the following packages
and libraries: Datetime, Numpy, Pandas, SciPy, Scikit Learn, and
Matplotlib. The project has been implemented on the Google
Colab platform using the CPU runtime. The CPU specifications
for Google Colab are; model: 79, CPU Family: 6, model name:
FIGURE 1 | Symptoms in patients.
Intel(R) Xeon(R) CPU @ 2.20 GHz and cache size: 56,320KB.
The storage used is Google Drive.
Dataset
The dataset used in this study was accessed fromKaggle as “Novel
Corona Virus 2019 Dataset” (26). The dataset has been compiled
from various sources including the World Health Organization
and John Hopkins University. However, this dataset has been
pre-processed further by us to meet the needs of this study.
Table 1 presents the features of the data.
Data Analysis
Fever, cough, cold, fatigue, body pain, and malaise were the most
common symptoms that were noticed in patients whose data is
available in this dataset and are shown in Figure 1.
Correlation between features of the dataset provides crucial
information about the features and the degree of influence they
have over the target value. The heat map of Pearson Correlation
between the features of the dataset is shown in Figure 2, which
clearly reveals a relatively stronger positive correlation between
age of the patient, whether the patient was native to Wuhan,
gap between (in days) when they first felt the symptoms and
visited the hospital, and death. However, the country of the
patient has a positive correlation with recovery. This implies that
foreign patients who visited China had a higher recovery rate.
There is also a strong positive correlation between symptom1 and
symptom2, and also between symptom2 and symptom3.
Data Pre-processing
The dataset consists of columns with the data being the Date,
String, and Numeric type. We also have categorical variables in
the dataset. Since theMLmodel requires all the data that is passed
as input to be in the numeric form, we performed label-encoding
of the categorical variables. This assigns a number to every unique
categorical value in the column.
The dataset consists of multiple missing values which cause
an error when passed directly as an input. Thus, we fill the
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FIGURE 2 | Correlation between data features.
missing values with “NA.” Certain patient data records contain
missing values for both the “death” and “recov” columns, such
patient records have been separated from the main dataset and
compiled into the test dataset, while the remaining records have
been compiled into the train dataset.
The dataset also consists of columns in the date format.
Since the data columns are not directly used, feature engineering
has been applied. A new column has been populated with the
corresponding (hosp_vis—sym_on) value. This provides us with
the number of days that have passed between the symptoms being
noticed and the patient visiting the hospital.
Evaluation Metrics
The purpose of the following study is to accurately predict the
outcome of a particular patient depending on multiple factors,
including but not limited to travel history, demographics etc.
Since this is a very crucial prediction, accuracy is very important.
Thus, for the purpose of evaluating the model we considered
three evaluation metrics for this study.
The following terms are used in the equations: TP, True
Positive; TN, True Negative; FP, False Positive; and FN,
False Negative.
Accuracy
Given a dataset consisting of (TP+TN) data points, the accuracy
is equal to the ratio of total correct predictions (TP + TN +
FP + FN) by the classifier to the total data points. Accuracy is an
important measure which is used to assess the performance of the
classification model. Accuracy is calculated as shown in Equation
(1) as follows:
Accuracy =
TP+ TN
TP+ TN+ FP+ FN
0.0 < Accuracy < 1.0
(1)
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FIGURE 3 | Evaluation metrics for decision tree.
Precision
Precision is equal to the ratio of the True Positive (TP) samples
to the sum of True Positive (TP) and False Positive (FP) samples.
Precision is also a key metric to identify the number of correctly
classified patients in an imbalanced class dataset. Precision is
calculated as given in Equation (2) as follows:
Precision =
TP
TP + FP
(2)
Recall
Recall is equal to the ratio of the True Positive (TP) samples
to the sum of True Positive (TP) and False Negative (FN)
samples. Recall is a significant metric to identify the number of
correctly classified patients in an imbalanced class dataset out of
all the patients that could have been correctly predicted. Recall is
calculated as given in Equation (3) as follows:
Recall =
TP
TP + FN
(3)
F1 Score
F1 Score is equal to the harmonic mean of Recall and Precision
value. The F1 Score strikes the perfect balance between Precision
and Recall thereby providing a correct evaluation of the model’s
performance in classifying COVID-19 patients. This is the most
significant measure that we will be using to evaluate the model.
F1 Score can be calculated as shown in Equation (4) as follows:
F1 Score = 2×
Precision× Recall
Precision + Recall
(4)
RESULTS
We have used the pre-processed dataset to train multiple ML
classification models. The models included in this study include:
Decision Tree Classifier, Support Vector Classifier, Gaussian
Naïve Bayes Classifier, and Boosted Random Forest Classifier.
FIGURE 4 | Evaluation metrics for SVM classifier.
FIGURE 5 | Evaluation metrics for Gaussian NB.
Since the dataset we used can be an imbalanced dataset, we
will be using F1 Score as the primary metric for comparison.
Figures 3–6 shows the model performances for all the models
stated above.
The decision tree constructed for estimating the target variable
is visualized in Figure 7. The decision tree has a depth of 2
and the Gini index of every node is <0.5, which indicates an
imbalance in the training data.
Since Boosted Random Forest algorithm is the best
performing model, we will fine tune the model for better
performance on the dataset.
DISCUSSION
Boosted Random Forest Classification
A Boosted Random Forest is an algorithm, which consists of two
parts; the boosting algorithm: AdaBoost and the Random Forest
classifier algorithm (27)—which in turn consists of multiple
decision trees. A decision tree builds models that are similar to an
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FIGURE 6 | Evaluation metrics for Boosted Random Forest.
FIGURE 7 | Decision tree.
actual tree. The algorithm divides our data into smaller subsets,
simultaneously adding branches to the tree. The outcome is a
tree consisting of leaf nodes and decision nodes. A decision node
has two or more branches representing the value of each feature
(like age, symptom1, etc.) tested and the leaf node holds the result
value on the patient’s prospective condition (target value).
Multiple classifier decision trees (ensemble of classifiers)
eliminate the risk of failure of a single decision tree to correctly
predict the target value. Thus, the random forest averages the
result provided by multiple trees to provide the final result.
The margin function for the random forest is expressed
in Equation (5), the generalization error in Equation (6),
and confidence in the prediction in Equation (7). Here
h1 (x) , h2 (x) , . . . , hk (x) is the ensemble of classifiers (decision
trees) and the training data is drawn from the vectors X,Y .
The margin function is expressed as follows:
mg (X, Y) = avkI
(
hk (X) = Y
)
−maxj 6=YavkI
(
hk (X) = j
)
(5)
where the indicator function is denoted by I(.). The
generalization error is given as follows:
PE∗ = PX,Y
(
mg (X, Y) < 0
)
(6)
FIGURE 8 | Decision tree 1.
where the probability is expressed over the X,Y space. In random
forests, we have hk (X) = h(X,Θk), therefore the number of
classifiers (decision trees) increases, for all the sequences of trees.
The probability PE∗ converges to Equation (7), from the Strong
Law of Large Numbers and tree structure.
PX,Y
(
P2
(
h (X,2) = Y
)
−maxj 6=YP2
(
h (X,2) = j
)
< 0
)
(7)
Applying the boosting algorithm AdaBoost (28) provides
a corrective mechanism to improve the model after every
prediction of patient state. Eventually, the decision is a result of
summing up of all the base models. It is one of the most efficient
techniques in ML.
The corrective mechanism can be expressed as follows
Equation (8). Given
(
x1, y1
)
, . . . ,
(
xm, ym
)
, where xi ∈ X, yi ∈
Y = {−1,+1}. For, t = 1, . . . ,T. Initialize D1 (i) =
1
m .
After training a weak learner, random forest in our case, using
distribution Dt .
Get the hypothesis, ht :X → {−1,+1} ,
With the error et = Pri∼Dt
[
ht (xi) 6= yi
]
After choosing αt =
1
2 ln ln
(
1−et
et
)
Update: Dt+1 (i) =
Dt(i)
Zt
× {e−αt if ht(xi) =
yi e
αt if ht(xi) 6= yi
=
Dt(i) exp(−αtyiht(xi))
Zt
Here, Zt is a normalization factor. We get the final hypothesis
as follows:
H (x) = sign
(
T∑
t = 1
αtht(x)
)
(8)
Here the dependent variable was the patient state
(dead/recovered) while the independent variables were location,
country, vis_wuhan, from_wuhan (hosp_vis—sym_on), age,
gender, symptom (1–6). We have used the boosted random forest
because of its accurate classification performance on imbalanced
datasets (25, 29).
The decision trees visualized in Figures 8–11 have a depth
equal to two. Also, the Gini index in all the leaf nodes of
all the trees is <0.5, which indicates the training dataset is
imbalanced. Hence, for optimizing the performance of the model
Frontiers in Public Health | www.frontiersin.org 6 July 2020 | Volume 8 | Article 357
Iwendi et al. COVID-19 Patient Health Prediction
FIGURE 9 | Decision tree 10.
FIGURE 10 | Decision tree 25.
FIGURE 11 | Decision tree 100.
we have reduced the depth of trees to 2 and increased the
number of estimators (decision trees) in the random forest to
100. This prevents high variance in the model and provides
accurate predictions.
Hyperparameter Optimization
Since the Boosted Random Forest Classifier was implemented
using the default parameters, for the optimal performance of
the model, we conducted a grid search over a grid of chosen
parameters to gain a set of best performing parameters. We
implemented the grid search using the GridSearchCV() function
TABLE 2 | Optimal hyperparameters returned by grid search.
Parameters Value
n_estimators 100
max_depth 2
min_samples_leaf 2
min_samples_split 2
criterion gini
TABLE 3 | Evaluation results.
Metric Score
Recall score 0.75
Precision score 1.0
F1 score 0.86
Accuracy 0.94
FIGURE 12 | Comparison of Models’ performance.
from Sklearn library. Table 2 presents the hyperparameters as
returned by the grid search algorithm (30).
Table 3 presents the evaluation metrics of the Fine Tuned
Boosted Random Forest.
The study shows that Boosted Random Forest performs better
while predicting COVID-19 patient deaths. Figure 12 graph
compares the performance of all the models including Boosted
Random Forest.
CONCLUSION AND FUTURE WORK
The application of Artificial Intelligence is very crucial to process
patient data for efficient treatment strategies. In this paper we
presented amodel that implements the Random Forest algorithm
boosted by the AdaBoost algorithm, with a F1 Score of 0.86
on the COVID-19 patient dataset. We have discovered that the
Boosted Random Forest algorithm provides accurate predictions
even on imbalanced datasets. The data analyzed in this study has
revealed that death rates were higher amongst theWuhan natives
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compared to non-natives. Also, male patients had a greater
death rate compared to female patients. The majority of affected
patients are aged between of 20 and 70 years.
Future work will focus on creating a pipeline that combines
CXR scanning computer vision models with these types of
demographic and healthcare data processing models. These
models will then be integrated into applications that will support
the growth of mobile healthcare. This can provide a step toward
a semi-autonomous diagnostic system that can provide rapid
screening and detection for COVID-19 affected regions and
prepare us for future outbreaks.
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